Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Anacor Pharmaceuticals Inc    ANAC

Delayed Quote. Delayed  - 04/28 09:35:28 pm
66.285 USD   -1.19%
04/01 ANACOR PHARMACE : Announces Pricing of Offering of $250 Million of 2..
03/30 ANACOR PHARMACE : Announces Proposed Offering of $250 Million of Con..
03/22 ANACOR PHARMACE : Announces FDA Acceptance of NDA for Crisaborole To..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/22/2016 04/25/2016 04/26/2016 04/27/2016 04/28/2016 Date
64.25(c) 65.99(c) 68.01(c) 67.08(c) 66.285 Last
694 266 664 943 1 200 515 813 166 469 305 Volume
+2.00% +2.71% +3.06% -1.37% -1.19% Change
More quotes
Financials ($)
Sales 2016 93,7 M
EBIT 2016 -43,3 M
Net income 2016 -60,4 M
Debt 2016 -
Yield 2016 -
Sales 2017 277 M
EBIT 2017 38,5 M
Net income 2017 5,14 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017 71,82
Capi. / Sales 2016 32,1x
Capi. / Sales 2017 10,9x
Capitalization 3 009 M
More Financials
Company
Anacor Pharmaceuticals, Inc. operates as a biopharmaceutical company, which focuses on discovering, developing and commercializing novel small-molecule therapeutics derived from its boron chemistry platform.The company has discovered following compounds that are currently in development including... 
More about the company
Surperformance© ratings of Anacor Pharmaceuticals Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ANACOR PHARMACEUTICALS INC
04/07 ANACOR PHARMACEUTICALS : Announces Proposed Offering of $250 Million of Converti..
04/07 ANACOR PHARMACEUTICALS : Announces Pricing of Offering of $250 Million of 2.00% ..
04/06 ANACOR PHARMACEUTICALS : Entry into a Material Definitive Agreement, Creation of..
04/01 ANACOR PHARMACEUTICALS : Other Events, Financial Statements and Exhibits (form 8..
04/01 ANACOR PHARMACEUTICALS : Announces Pricing of Offering of $250 Million of 2.00% ..
03/31 ANACOR PHARMACEUTICALS : Announces FDA Acceptance of NDA for Crisaborole Topical..
03/30 ANACOR PHARMACEUTICALS : Other Events, Financial Statements and Exhibits (form 8..
03/30 ANACOR PHARMACEUTICALS : Announces Proposed Offering of $250 Million of Converti..
More news
Sector news : Biotechnology & Medical Research - NEC
07:04p Sanofi launches $9.3 billion fight for U.S. cancer firm Medivation
06:22pDJSanofi Makes Offer for Medivation in $9.3 Billion Deal--3rd Update
03:44pDJCELGENE : Cuts 2017 Guidance, Affirms Longer-Term Targets
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
04/19 Midday Gainers/ Losers
04/07 Anacor Looks Much Better Now
04/01 Anacor Pharma prices $250M debt offering
03/30 Anacor Pharma readies $250M convertible debt offering
03/23 INSIDERINSIGHTS.COM DAILY ROUND UP 3 : Cvgi, erc, cik


Comments 
Advertisement
Chart ANACOR PHARMACEUTICALS INC
Duration : Period :
Anacor Pharmaceuticals Inc Technical Analysis Chart | ANAC | US0324201013 | 4-Traders
Full-screen chart
Technical analysis trends ANACOR PHARMACEUT...
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions